OSR Health OSRHW
NASDAQ OSRHW
$0.05 +0.01 (+40.73%)
As of: Aug 24, 2026 · 3:58 PM EDT

OSR Health (OSRHW) Debt Ratio (2024 - 2026)

OSR Health (OSRHW) posted Debt Ratio of 0.0 for Q1 2026, down 79.89% sequentially from 0.01 in Q4 2025, and down 4.47% YoY from 0.0 in Q1 2025.

OSR Health (OSRHW) Debt Ratio (2024 - 2026) Analysis & Trends

OSR Health has reported Debt Ratio for 3 years, with the latest figure at 0.0 in Q1 2026.

  • Quarterly Debt Ratio fell 4.47% year-over-year to 0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0 (down 4.47% YoY) and the FY2025 annual result came in at 0.01, up 3.5% from the prior year.
  • Debt Ratio eased to 0.0 in Q1 2026 per OSRHW's latest filing, from 0.01 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.08 in Q3 2024 and troughed at 0.0 in Q1 2026.
  • A 3-year average of 0.02 and a median of 0.01 in 2025 frame the typical range for Debt Ratio.
  • The widest YoY moves for Debt Ratio: up 3.5% in 2025, down 87.65% in 2025.
  • Over 3 years, Debt Ratio stood at 0.01 in 2024, then gained by 3.5% to 0.01 in 2025, then plunged by 79.89% to 0.0 in 2026.
  • According to Business Quant data, Debt Ratio over the past three periods registered 0.0, 0.01, and 0.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 138.97 Bn 131.12 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.15 Bn 77.15 Bn 3.93 Bn 0.05
3 Argenx Se 62.84 Bn 57.65 Bn 1.37 Bn -
4 Moderna 55.74 Bn 50.60 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.53 Bn 36.43 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.60 Bn 28.29 Bn 992.69 Mn -
7 BioNTech SE 27.32 Bn 8.93 Bn 668.28 Mn 0.03
8 Royalty Pharma 27.29 Bn 26.45 Bn - 0.47
9 Insmed 26.99 Bn 25.83 Bn 358.27 Mn 0.26
10 OSR Health 1.40 Mn 20.39 Mn 86,605.00 0.01

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.01
Sep 30, 2025 0.01
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.01
Sep 30, 2024 0.08